Physician profile
Melanie Ames
NPI 1548754476
$2,020.22
in general payments reported to CMS, 2019-2025
27 companies · $83.96 in 2025
The $83.96 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $438 · 2022: $142 · 2023: $236 · 2024: $1,120 · 2025: $83.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $317.46 | 2024 | Epclusa, Descovy |
| Lilly USA, LLC | $201.51 | 2021-2025 | Mounjaro, Zepbound |
| Inspire Medical Systems, INC. | $171.38 | 2024 | Inspire |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Eisai INC. | $125.00 | 2024 | |
| Abbvie INC. | $122.58 | 2024 | |
| Biocryst US Sales Co., LLC | $111.38 | 2023 | Orladeyo |
| Biohaven Pharmaceutical Holding Company LTD. | $111.37 | 2022 | |
| Amarin Pharma, INC. | $104.98 | 2021 | |
| Dexcom, INC. | $79.41 | 2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $57.07 | 2021 | |
| Exact Sciences Corporation | $46.19 | 2024 | Cologuard Collection Kit |
| Arbor Pharmaceuticals, INC. | $44.13 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $44.07 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $36.96 | 2021 | |
| Glaxosmithkline, LLC. | $21.52 | 2025 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $20.96 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $20.23 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.75 | 2021 | |
| Jazz Pharmaceuticals INC. | $19.16 | 2021 | |
| Philips North America LLC | $18.15 | 2024 | (Ck6) Holter |
| Abbott Laboratories | $17.40 | 2021 | |
| Antares Pharma, INC. | $16.86 | 2022 | |
| Kaleo, INC. | $15.83 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.39 | 2021 | |
| Mylan Specialty L.P. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Ames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.